superRCA published in Nature Communications

With an innovative, super sensitive technology, so-called superRCA, remaining cancer cells can be detected after treatment of acute myeloid leukemia (AML). The method is presented in an article in Nature Communication. The technology, superRCA, tracks mutations with greater sensitivity than PCR-based technologies and can detect recurrence of cancer earlier. The technology is fast, sensitive, reliable…